Sort
16,300 grants matching “fatty liver disease”
IGF2 causes DNA damage in liver cancer
$0Nicholas J Webster · Va San Diego Healthcare System · I01 · FY2025 · VA
Bile Acids and Sphingosine 1-Phosphate in Non-Alcoholic Steatohepatitis (NASH)
$0Huiping Rose Zhou · Va Veterans Administration Hospital · I01 · FY2025 · VA
Regulation of Intestinal Bile Acid Absorption in Health and Cholesterol-Related Disorders
$0Waddah A Alrefai · Jesse Brown Va Medical Center · I01 · FY2025 · VA
Genetics of Cardiometabolic Diseases in the VA Population
$0Kyong-Mi Chang · Philadelphia Va Medical Center · I01 · FY2025 · VA
Lysophosphatidic acid and cardiovascular disease risk
$0Andrew J Morris · Va Medical Center - Lexington, Ky · I01 · FY2017 · VA
Alcohol Alters Hepatic Immune Function: Role of the Asialoglycoprotein Receptor
$0Benita McVicker · Omaha Va Medical Center · I01 · FY2012 · VA
BLR&D Research Career Scientist Award Application
$0Huiping Rose Zhou · Va Veterans Administration Hospital · IK6 · FY2025 · VA
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
$0Roger H. Unger · Va North Texas Health Care System · I01 · FY2017 · VA
Liver Inflammation and Injury: Molecular Mechanisms
$0Mario Chojkier · Va San Diego Healthcare System · I01 · FY2012 · VA
Leptin Signaling in Humans
$0Christos S Mantzoros · Va Boston Health Care System · I01 · FY2012 · VA
BLR&D Research Career Scientist Award Application
$0Yun-Fai Chris Lau · Veterans Affairs Med Ctr San Francisco · IK6 · FY2020 · VA
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease
$0Anne S Henkel · Jesse Brown Va Medical Center · I01 · FY2020 · VA
Tissue specific production of RBP4 and mechanism of insulin resistance
$0Timothy Eugene Graham · Va Salt Lake City Healthcare System · I01 · FY2012 · VA
Analysis of Lipolytic Trafficking in Muscle
$0James G Granneman · John D Dingell Va Medical Center · I01 · FY2012 · VA
Leveraging Novel Sources of Data with Analytic Morphomics to Improve Delivery of Specialty Care to At-Risk Veterans with Liver Disease
$0Grace L. Su · Veterans Health Administration · I01 · FY2020 · VA
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)
$0George Ioannou · Va Puget Sound Healthcare System · I01 · FY2020 · VA
THE ROLE OF ACETYLATION IN MITOCHONDRIAL FUNCTION
$0Gary Cecchini · Veterans Affairs Med Ctr San Francisco · I01 · FY2014 · VA
Validation of Patient-Specific, iPSC-based In Vitro Liver System
$0Jason A Wertheim · Southern Arizona Va Health Care System · I21 · FY2024 · VA
Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care
$0Shari S Rogal · Veterans Health Administration · I50 · FY2020 · VA
Promoting metabolic health through the reduction of dietary branched chain amino acids
$0Dudley William Lamming · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2020 · VA
Credentialing metabolic disease genes through human genetics and functional genomics
$0Amit Majithia · Va San Diego Healthcare System · I01 · FY2024 · VA
Hormonal control of NASH development and progression
$0Rhonda D. Kineman · Jesse Brown Va Medical Center · I01 · FY2024 · VA
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
$0Susanna Naggie · Durham Va Medical Center · I01 · FY2024 · VA
Paracrine Mechanisms of Prostate Cancer Metastatic Progression
$0Neil A Bhowmick · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA
Molecular mechanisms of Insulin resistance under chronic stress
$0Yang K Xiang · Va Northern California Health Care Sys · I01 · FY2017 · VA